Vijaya Diagnostic Centre Limited (NSE: VIJAYA) reports Q2 & H1 FY27 results with 26.7% YoY revenue growth, driven by strong operational performance.
Dr. Lal Path Labs Ltd. (LALPATHLAB) reports a 19.1% revenue growth and 27.2% PAT increase in Q1 FY27.